Mount Sinai Clinical Core for Alzheimer's research
Official title: Core B - Clinical Core
Funded at Icahn School of Medicine at Mount Sinai · NIH-11362249 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check NIH RePORTER for its current status.
This program builds and follows a group of older adults with and without memory problems to support Alzheimer's research.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11362249 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are older adults with normal cognition, mild cognitive impairment, or Alzheimer's dementia who can attend clinic visits and are willing to undergo imaging and provide biospecimens.
✕Less likely to help
People seeking immediate therapeutic benefit or those unable to attend in-person visits or provide samples may not receive direct benefit from participating.
What this research studies
If I join, the Clinical Core would record my memory tests, medical history, brain scans, and collect blood or other samples, then follow me over time. The team keeps a diverse group of participants across the range from normal thinking to different stages of dementia and makes the data and samples available to Mount Sinai and national Alzheimer’s research networks. That support helps researchers plan clinical trials, study disease progression, and look for biomarkers. Participation typically involves clinic visits, cognitive testing, imaging, and biospecimen donation.
Why it matters
Potential benefit: By creating a well-characterized group of participants and samples, it could speed development of better tests and treatments for Alzheimer's disease.
How similar studies have gone: Other consortia and cores (for example ADNI and NACC) have successfully used similar cohorts and biospecimens to advance biomarkers and trials for Alzheimer's disease.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Grossman, Hillel — Icahn School of Medicine at Mount Sinai
- Study coordinator: Grossman, Hillel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.